Evidence map›Paper›PMID 26572318›Full record

ReviewThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception2016

Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.

Rossella E Nappi, Andrew M Kaunitz, Johannes Bitzer

Open access · hybridAbstract readReview
In one paragraph

Review in The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Meta-Analysis of the Efficacy and Safety of Tranexamic Acid in Spinal Surgery.Computational and mathematical methods in medicine · 2022
    Pooled it
  3. Trial
  4. Menstrual Suppression in Gender Minority YouthJournal of clinical research in pediatric endocrinology · 2022
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Rossella E Nappia Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, Department of Obstetrics and Gynaecology , IRCCS San Matteo Foundation, University of Pavia , Pavia , Italy.
Andrew M Kaunitzb Department of Obstetrics and Gynecology , University of Florida College of Medicine-Jacksonville , Jacksonville , FL , USA.
Johannes Bitzerc Department of Obstetrics and Gynaecology , Basel University Hospital , Basel , Switzerland.
Jacksonville University · USUniversity Hospital of Basel · CHUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe clinical utility of extended regimen combined oral contraceptives (COCs) is increasingly being recognised. Our objective was to understand the attitudes of women and clinicians about the use of these regimens. We present the rationale for extended regimen COCs from a historical perspective, and trace their evolution and growing popularity in light of their clinical benefits. We conclude by offering potential strategies for counselling women about extended regimen COC options.

methodsWe conducted a MEDLINE search to identify and summarise studies of extended regimen COCs, focusing on attitudes of women and clinicians regarding efficacy, safety/tolerability and fewer scheduled bleeding episodes and other potential benefits.

resultsThe body of contemporary literature on extended regimen COCs suggests that their contraceptive efficacy is comparable to that of conventional 28-day (i.e., 21/7) regimens. For women seeking contraception that allows infrequent scheduled bleeding episodes, particularly those who suffer from hormone withdrawal symptoms and cyclical symptoms (e.g., headache, mood changes, dysmenorrhoea, heavy menstrual bleeding), extended regimen COCs are an effective and safe option. Although satisfaction with extended regimen COCs in clinical trials is high, misperceptions about continuous hormone use may still limit the widespread acceptance of this approach.

conclusionsDespite the widespread acceptance among clinicians of extended regimen COCs as an effective and safe contraceptive option, these regimens are underused, likely due to a lack of awareness about their availability and utility among women. Improved patient education and counselling regarding the safety and benefits of extended regimen COCs may help women make more informed contraceptive choices.

Indexed as

Attitude of Health PersonnelMenstruationPatient Acceptance of Health CarePatient SatisfactionContraceptives, Oral, CombinedContraceptives, Oral, HormonalDrug Administration ScheduleFemaleHumansContraceptives, Oral, CombinedContraceptives, Oral, HormonalBleedingClinician attitudesCombined hormonal contraceptionMenstrual suppressionOral contraceptivesPatient satisfaction

Identifiers

PMID26572318
PMCPMC4841029
OpenAlexW2178957235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.